Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rapid Dose Therapeutics Corp. plans to issue common shares to its non-management directors as a means of settling $150,000 in director fees, aiming to improve its financial position by reducing liabilities. This shares-for-debt transaction will not create a new control person and complies with Canadian regulatory exemptions.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.
